Correlation Between ATyr Pharma and Seres Therapeutics
Can any of the company-specific risk be diversified away by investing in both ATyr Pharma and Seres Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ATyr Pharma and Seres Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ATyr Pharma and Seres Therapeutics, you can compare the effects of market volatilities on ATyr Pharma and Seres Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ATyr Pharma with a short position of Seres Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of ATyr Pharma and Seres Therapeutics.
Diversification Opportunities for ATyr Pharma and Seres Therapeutics
0.09 | Correlation Coefficient |
Significant diversification
The 3 months correlation between ATyr and Seres is 0.09. Overlapping area represents the amount of risk that can be diversified away by holding ATyr Pharma and Seres Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Seres Therapeutics and ATyr Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ATyr Pharma are associated (or correlated) with Seres Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Seres Therapeutics has no effect on the direction of ATyr Pharma i.e., ATyr Pharma and Seres Therapeutics go up and down completely randomly.
Pair Corralation between ATyr Pharma and Seres Therapeutics
If you would invest 78.00 in Seres Therapeutics on August 31, 2024 and sell it today you would earn a total of 14.00 from holding Seres Therapeutics or generate 17.95% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
ATyr Pharma vs. Seres Therapeutics
Performance |
Timeline |
ATyr Pharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Seres Therapeutics |
ATyr Pharma and Seres Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with ATyr Pharma and Seres Therapeutics
The main advantage of trading using opposite ATyr Pharma and Seres Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ATyr Pharma position performs unexpectedly, Seres Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Seres Therapeutics will offset losses from the drop in Seres Therapeutics' long position.ATyr Pharma vs. Mereo BioPharma Group | ATyr Pharma vs. Terns Pharmaceuticals | ATyr Pharma vs. PDS Biotechnology Corp | ATyr Pharma vs. Inozyme Pharma |
Seres Therapeutics vs. Syros Pharmaceuticals | Seres Therapeutics vs. Iovance Biotherapeutics | Seres Therapeutics vs. Veracyte | Seres Therapeutics vs. Fate Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Complementary Tools
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |